Exact Mass: 509.3352352

D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D014704 - Veratrum Alkaloids Origin: Plant; SubCategory_DNP: Steroidal alkaloids, Veratrum alkaloids

Acetylbrowniine

Browniine 14-O-acetate

Tricornine

Cevine

Cevane-3-beta,4-beta,12,14,16-beta,17,20-heptol, 4,9-epoxy-

Narbomycin

A macrolide antibiotic that is narbonolide having a 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residue attached at position 6. It is biosynthesised by Streptomyces venezuelae.

UNC0638

2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine

C30H47N5O2 (509.3729562)

2-[4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(octyloxy)phenol

FDA permitted light stabiliser for food-contact olefinic polymers. FDA permitted light stabiliser for food-contact olefinic polymers

LysoPE(0:0/20:0)

(2-Aminoethoxy)[(2R)-3-hydroxy-2-(icosanoyloxy)propoxy]phosphinic acid

LysoPE(0:0/20:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/20:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

LysoPC(17:0/0:0)

(2-{[(2R)-3-(heptadecanoyloxy)-2-hydroxypropyl phosphono]oxy}ethyl)trimethylazanium

LysoPC(17:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(17:0), in particular, consists of one chain of margaric acid at the C-1 position. The margaric acid moiety is derived from butter, milk and fat of ruminants. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(17:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(17:0), in particular, consists of one chain of margaric acid at the C-1 position. The margaric acid moiety is derived from butter, milk and fat of ruminants. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.

LysoPC(O-18:0)

(2-{[(2R)-2-hydroxy-3-(octadecyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C26H56NO6P (509.3845046)

1-Octadecyl-sn-glycero-3-phosphocholine is an intermediate in the ether lipid metabolism pathway. 1-Octadecyl-sn-glycero-3-phosphocholine is irreversibly produced from 2-acetyl-1-(9Z-octadecenyl)-sn-glycero-3-phosphocholine via the enzyme 1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47). 1-Octadecyl-sn-glycero-3-phosphocholine is an ether phospho-ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol are bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. 1-Octadecyl-sn-glycero-3-phosphocholine is an intermediate in the ether lipid metabolism pathway. 1-Octadecyl-sn-glycero-3-phosphocholine is irreversibly produced from 2-acetyl-1-(9Z-octadecenyl)-sn-glycero-3-phosphocholine via the enzyme 1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47). 1-Octadecyl-sn-glycero-3-phosphocholine is an ether phospho-ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol are bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage.

LysoPE(20:0/0:0)

(2-aminoethoxy)[(2R)-2-hydroxy-3-(icosanoyloxy)propoxy]phosphinic acid

LysoPE(20:0/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(20:0/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

Cholylthreonine

3-hydroxy-2-(4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)butanoic acid

Cholylthreonine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholylthreonine consists of the bile acid cholic acid conjugated to the amino acid Threonine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholylthreonine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholylthreonine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

Colforsin daropate

(5-acetyloxy-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-6-yl) 3-(dimethylamino)propanoate

1,2-Dioctanoyl PC

1,2-bis(O-octanoyl)-sn-glyceryl-phophorylcholine

His Val Leu Lys

2-O-ethyl PAF C-16

1-O-hexadecyl-2-O-ethyl-sn-glyceryl-3-phosphorylcholine

Phosphatidylethanolamine lyso 20:0

C27H43NO8_Cevane-3,4,7,14,15,16,20-heptol, 4,9-epoxy-, (3beta,4alpha,7alpha,15alpha,16beta)

NCGC00180429-03_C27H43NO8_Cevane-3,4,7,14,15,16,20-heptol, 4,9-epoxy-, (3beta,4alpha,7alpha,15alpha,16beta)-

(1S,2S,6S,9S,10S,11R,12R,13S,14S,15S,16R,18S,19S,22S,23R,25R)-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosane-10,12,13,14,16,22,23-heptol

(1S,2S,6S,9S,10S,11R,12R,13S,14S,15S,16R,18S,19S,22S,23R,25R)-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosane-10,12,13,14,16,22,23-heptol

1-heptadecanoyl-sn-glycero-3-phosphocholine

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine

A lysophosphatidylcholine 17:0 in which the acyl group at position 1 is 1-heptadecanoyl and the hydroxy group at position 2 is unsubstituted. CONFIDENCE standard compound; INTERNAL_ID 262

LPC 17:0-d5

His Ile Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylpentanamido]hexanoic acid

His Ile Ile Gln

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylpentanamido]-4-carbamoylbutanoic acid

His Ile Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]hexanamido]-3-methylpentanoic acid

His Ile Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]hexanamido]-4-methylpentanoic acid

His Ile Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-methylpentanamido]hexanoic acid

His Ile Leu Gln

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-methylpentanamido]-4-carbamoylbutanoic acid

His Ile Gln Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-carbamoylbutanamido]-3-methylpentanoic acid

His Ile Gln Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-carbamoylbutanamido]-4-methylpentanoic acid

His Lys Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylpentanamido]-3-methylpentanoic acid

His Lys Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylpentanamido]-4-methylpentanoic acid

His Lys Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-methylpentanamido]-3-methylpentanoic acid

His Lys Leu Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-methylpentanamido]-4-methylpentanoic acid

His Leu Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-methylpentanamido]hexanoic acid

His Leu Ile Gln

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-methylpentanamido]-4-carbamoylbutanoic acid

His Leu Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]hexanamido]-3-methylpentanoic acid

His Leu Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]hexanamido]-4-methylpentanoic acid

His Leu Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-methylpentanamido]hexanoic acid

His Leu Leu Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-methylpentanamido]-4-carbamoylbutanoic acid

His Leu Gln Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-carbamoylbutanamido]-3-methylpentanoic acid

His Leu Gln Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-carbamoylbutanamido]-4-methylpentanoic acid

His Gln Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-methylpentanamido]-3-methylpentanoic acid

His Gln Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-methylpentanamido]-4-methylpentanoic acid

His Gln Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-4-methylpentanamido]-3-methylpentanoic acid

His Gln Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-4-methylpentanamido]-4-methylpentanoic acid

His Arg Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylbutanoic acid

His Val Arg Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

His Val Val Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

Ile His Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]hexanoic acid

Ile His Ile Gln

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-carbamoylbutanoic acid

Ile His Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylpentanoic acid

Ile His Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-methylpentanoic acid

Ile His Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]hexanoic acid

Ile His Leu Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-carbamoylbutanoic acid

Ile His Gln Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-methylpentanoic acid

Ile His Gln Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-4-methylpentanoic acid

Ile Ile His Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

Ile Ile His Gln

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

Ile Ile Lys His

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

Ile Ile Gln His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

Ile Lys His Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

Ile Lys His Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

Ile Lys Ile His

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Ile Lys Leu His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Ile Leu His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

Ile Leu His Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

Ile Leu Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

Ile Leu Gln His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

Ile Gln His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

Ile Gln His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

Ile Gln Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carbamoylbutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Ile Gln Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carbamoylbutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Lys His Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylpentanoic acid

Lys His Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-methylpentanoic acid

Lys His Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-methylpentanoic acid

Lys His Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-methylpentanoic acid

Lys Ile His Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

Lys Ile His Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

Lys Ile Ile His

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Lys Ile Leu His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Lys Leu His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

Lys Leu His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

Lys Leu Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Lys Leu Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Leu His Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]hexanoic acid

Leu His Ile Gln

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-carbamoylbutanoic acid

Leu His Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylpentanoic acid

Leu His Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-methylpentanoic acid

Leu His Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]hexanoic acid

Leu His Leu Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-carbamoylbutanoic acid

Leu His Gln Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-methylpentanoic acid

Leu His Gln Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-4-methylpentanoic acid

Leu Ile His Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

Leu Ile His Gln

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

Leu Ile Lys His

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

Leu Ile Gln His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

Leu Lys His Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

Leu Lys His Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

Leu Lys Ile His

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Leu Lys Leu His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Leu Leu His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

Leu Leu His Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

Leu Leu Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

Leu Leu Gln His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

Leu Gln His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

Leu Gln His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

Leu Gln Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Leu Gln Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Gln His Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylpentanoic acid

Gln His Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-methylpentanoic acid

Gln His Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-methylpentanoic acid

Gln His Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-methylpentanoic acid

Gln Ile His Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

Gln Ile His Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

Gln Ile Ile His

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Gln Ile Leu His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Gln Leu His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

Gln Leu His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

Gln Leu Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Gln Leu Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

Arg His Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylbutanoic acid

Arg Val His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

Arg Val Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

Val His Arg Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

Val His Val Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

Val Arg His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

Val Arg Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

Val Val His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

Val Val Arg His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

PC(14:0/2:0)

3,5,9-Trioxa-4-phosphatricosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-

PC(8:0/8:0)

Choline, hydroxide, dihydrogen phosphate, inner salt, ester with 1,2-dioctanoin, L-

PC(8:0/8:0)[S]

3,5,9-Trioxa-4-phosphaheptadecan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxooctyl)oxy]-, inner salt, 4-oxide, (S)-

Dioctanoyl phosphatidylcholine

1-octanoyl-2-octanoyl-sn-glycero-3-phosphocholine

PC(O-1:0/16:0)

3,5,8-Trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-7-(methoxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (R)-

Platelet-activating factor

3,5,9-Trioxa-4-phosphatetracosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

PC(O-16:0/1:0)

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-(formyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

PC(16:0/O-1:0)[U]

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide

PC(O-10:0/O-8:0)[U]

3,5,9-Trioxa-4-phosphanonadecan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-(octyloxy)-, inner salt, 4-oxide

PC(O-16:0/O-2:0)

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-ethoxy-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

PC(O-16:0/O-2:0)[U]

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-ethoxy-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide

PC(O-17:0/O-1:0)[U]

3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, inner salt, 4-oxide

PC(O-2:0/O-16:0)[U]

3,5,8-Trioxa-4-phosphatetracosan-1-aminium, 7-(ethoxymethyl)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide

PC(O-9:0/O-9:0)[U]

3,5,9-Trioxa-4-phosphaoctadecan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-(nonyloxy)-, inner salt, 4-oxide

PC(17:0/0:0)

3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-

PC(17:0/0:0)[U]

3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide

Ro 14-8160

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

PC(O-18:0/0:0)[S]

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (S)-

Ro 14-0859

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (1)-

PE(9:0/10:0)[U]

Decanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxononyl)oxy]ethyl ester

PE(10:0/9:0)[U]

1-decanoyl-2-nonanoyl-sn-glycero-3-phosphoethanolamine

Lyso-PAF c-18

1-O-Octadecyl-sn-glyceryl-3-phosphorylcholine

LPE(20:0)

1-Arachidonyl-2-hydroxy-sn-glycero-3-phosphoethanolamine

LPC(17:0)

1-Heptadecanoyl-glycero-3-phosphocholine

PC(16:0/O-1:0)

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-

PE(20:0/0:0)

1-eicosanoyl-glycero-3-phosphoethanolamine

PS(P-18:0/0:0)

1-(1Z-octadecenyl)-glycero-3-phosphoserine

Cysorb uv-1164

2-[4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(octyloxy)phenol

NKH477

(3Z)-3-[{1,6-Dimethyl-2-[(1E,3E)-1,3-pentadien-1-yl]-1,2,4a,5,6,7,8,8a-octahydro-1-naphthalenyl}(hydroxy)methylene]-5-(1-hydroxyethyl)-2,4-pyrrolidinedione

PC 16:0

1-tetradecanoyl-2-acetyl-sn-glycero-3-phosphocholine

PC O-17:0

1-methyl-2-hexadecanoyl-sn-glycero-3-phosphocholine

LPC 17:0

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine

CONFIDENCE standard compound; INTERNAL_ID 262

LPC O-17:1;O

1-O-(2-methoxy-4Z-hexadecenyl)-sn-glycero-3-phosphocholine

LPE 20:0

2-eicosanoyl-sn-glycero-3-phosphoethanolamine

LPS O-18:1

1-(1Z-octadecenyl)-glycero-3-phosphoserine

Cevin

Cevane-3,4,12,14,16,17,20-heptol,4,9-epoxy-, (3a,4a,16b)-

D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D014704 - Veratrum Alkaloids

Barverine

C29H43N5O3 (509.3365728)

2,4-Bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-iso-octyloxyphenyl)-1,3,5-triazine

Acetyl tetrapeptide-3

Unii-63P7W7886U

C29H40FN5O2 (509.3165872)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D065100 - CCR5 Receptor Antagonists

Colforsin daropate

1-O-Hexadecyl-2-O-ethyl-SN-glycero-3-phosphorylcholine

1,2-Octanoylphosphatidylcholine

(3-Hydroxy-2-octadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Heptadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

1-O-Hexadecyl-2-O-ethyl-sn-glycero-3-phosphocholine

1-Oleoyl-sn-glycero-3-phospho-(1-sn-glycerol)

a 2-acyl-sn-glycero-3-phosphoglycerol (n-C18:1)

Cholylthreonine

Veracevine

Cevane-3-beta,4-beta,12,14,16-beta,17,20-heptol, 4,9-epoxy-

A cyclic hemiketal that is cevane that has an oxygen bridge from the 4alpha to the 9 position and is substituted by hydroxy groups at the 3beta, 4beta, 12, 14, 16beta, 17, and 20 positions.

1-hexadecanoyl-2-methyl-sn-glycero-3-phosphocholine

C25H43N5O6 (509.32131780000003)

A 1-acyl-2-alkyl-sn-glycero-3-phosphocholine in which the acyl and alkyl groups at posiitons 1 and 2 are specified respectively as hexadecanoyl and methyl.

(2S)-4-methyl-2-[[[5-[[5-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]pentylamino]-oxomethyl]-1H-imidazol-4-yl]-oxomethyl]amino]pentanoic acid tert-butyl ester

2-Oleoyl-lysophosphatidylglycerol

(2S)-2,3-dihydroxypropyl (2S)-2-hydroxy-3-{[(9Z)-octadec-9-enoyl]oxy}propyl phosphate

(2S)-2,3-dihydroxypropyl (2S)-3-hydroxy-2-{[(9Z)-octadec-9-enoyl]oxy}propyl phosphate

(2R)-2,3-dihydroxypropyl (2R)-3-hydroxy-2-{[(9Z)-octadec-9-enoyl]oxy}propyl phosphate

1-Octadecanoyl-2-acyl-sn-glycero-3-phosphoethanolamine

1-Oleoyl-sn-glycero-3-phosphoglycerol(1-)

N-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

N-[(4S,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxybenzamide

N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

N-[(4S,7S,8S)-8-methoxy-5-[(4-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

N-[(4R,7R,8R)-8-methoxy-5-[(4-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(4S,7S,8R)-8-methoxy-5-[(4-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

N-[(4R,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxybenzamide

N-[(4S,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxybenzamide

N-[(4R,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxybenzamide

N-[(5S,6S,9S)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-methoxybenzamide

N-[(5R,6S,9R)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-methoxybenzamide

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[(4-phenoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone

N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

C30H43N3O4 (509.32533980000005)

N-[[(2R,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

N-[[(2R,3R)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

C30H43N3O4 (509.32533980000005)

N-[(4R,7R,8S)-8-methoxy-5-[(4-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(4R,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxybenzamide

N-[(4R,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxybenzamide

N-[(4S,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxybenzamide

N-[(4S,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxybenzamide

N-[(5S,6R,9R)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-methoxybenzamide

N-[(5R,6R,9R)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-methoxybenzamide

N-[(5R,6R,9S)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-methoxybenzamide

N-[(5S,6S,9R)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-methoxybenzamide

N-[(5S,6R,9S)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-methoxybenzamide

N-icosanoyl-sn-glycero-3-phosphoethanolamine

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-formyloxypropyl] octadecanoate

CID 5458458

D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D014704 - Veratrum Alkaloids

(4alpha,5xi,7alpha,13xi,15alpha)-4,9-Epoxycevane-3,4,7,14,15,16,20-heptol

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] icosanoate

(1S,2S,6S,9S,10S,11R,12R,13S,14S,15S,16R,18S,19S,22S,23R,25R)-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosane-10,12,13,14,16,22,23-heptol

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] hexadecanoate

Ldgcc 18:4

2-Aminoethyl (3-henicosoxy-2-hydroxypropyl) hydrogen phosphate

Lnape 5:0/N-14:0

Lnape 16:0/N-3:0

Lnape 13:0/N-6:0

Lnape 2:0/N-17:0

Lnape 9:0/N-10:0

Lnape 3:0/N-16:0

Lnape 10:0/N-9:0

Lnape 4:0/N-15:0

Lnape 15:0/N-4:0

Lnape 17:0/N-2:0

Lnape 7:0/N-12:0

Lnape 12:0/N-7:0

Lnape 14:0/N-5:0

Lnape 8:0/N-11:0

Lnape 11:0/N-8:0

Lnape 6:0/N-13:0

(2-Nonanoyloxy-3-octoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Nonoxy-2-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Acetyloxy-3-pentadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] dodecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] undecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] heptanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] nonanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] propanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] octanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] pentanoate

(2-Butanoyloxy-3-tridecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Dodecoxy-2-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexanoyloxy-3-undecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Decoxy-2-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] decanoate

(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxydodec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]dec-4-ene-1-sulfonic acid

3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]decane-1-sulfonic acid

(4E,8E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxydodeca-4,8-diene-1-sulfonic acid

(2-Propanoyloxy-3-tetradecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

4-[3-acetyloxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine-d5

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] acetate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] butanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] hexanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] decanoate

(3-Pentanoyloxy-2-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Butanoyloxy-2-dodecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] tridecanoate

(2-Decanoyloxy-3-hexanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Heptanoyloxy-2-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Acetyloxy-2-tetradecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] pentadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] tetradecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] undecanoate

(3-Propanoyloxy-2-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] heptadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] dodecanoate

C29H51NO6 (509.37161860000003)

lysoDGTS 19:3

2-[(2-Acetamido-3-hydroxyoctadecoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Decanoylamino)-3-hydroxydecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(pentanoylamino)pentadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[[2-(Hexanoylamino)-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(propanoylamino)heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(nonanoylamino)undecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[[2-(Dodecanoylamino)-3-hydroxyoctoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Butanoylamino)-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(octanoylamino)dodecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(undecanoylamino)nonoxy]phosphoryl]oxyethyl-trimethylazanium

2-[[2-(Heptanoylamino)-3-hydroxytridecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

14-O-Acetylbrowniine

An acetate ester obtained by acetylation of the O-14 position of browniine.

Ultraviolet Absorbent UV-1164

2-(4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(octyloxy)phenol

1-octadecylglycero-3-phosphocholine

1-O-Octadecyl-sn-glycero-3-phosphocholine

A 1-alkylglycero-3-phosphocholine in which the alkyl group is specified as octadecyl.

1-eicosanoyl-glycero-3-phosphoethanolamine

LysoPE(0:0/20:0)

1,2-dioctanoyl-sn-glycero-3-phosphocholine

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at positions 1 and 2 are specified as octanoyl.

1-pentadecyl-2-acetyl-sn-glycero-3-phosphocholine

A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl and the acyl groups at positions 1 and 2 are specified as pentadecyl and acetyl respectively.

1-tetradecanoyl-2-acetyl-sn-glycero-3-phosphocholine

1-hexadecyl-2-formyl-sn-glycero-3-phosphocholine

A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl and the acyl groups at positions 1 and 2 are specified as hexadecyl and formyl respectively.

1-methyl-2-hexadecanoyl-sn-glycero-3-phosphocholine

A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl and the acyl groups at positions 1 and 2 are specified as methyl and hexadecanoyl respectively.

1-(1Z-octadecenyl)-glycero-3-phosphoserine

1-O-(2-methoxy-4Z-hexadecenyl)-sn-glycero-3-phosphocholine

lysophosphatidylcholine 17:0

An lysophosphatidylcholine in which the acyl group contains seventeen carbons and no double bonds. If R1 is an acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphoethanolaminecholine. If R1 is a hydrogen and R2 is an acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.

3-isopropyl-15-methyl-6,9,12-tris(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

C26H47N5O5 (509.3577012)

(2-{[(2r)-2-hydroxy-3-(octadecyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-propyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C25H43N5O6 (509.32131780000003)

2-{[(1-{[(3z)-2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6-trien-8-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl)-c-hydroxycarbonimidoyl]amino}-3-methylpentanoic acid

(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9-dihydroxy-4,6,16-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate